LehmannH.E., BanT.A.: “Early Clinical Drug Evaluation Unit”. Report from Douglas Hospital. E.C.D.U.E. Meeting. Washington, D.C. 1969.
8.
LeonardD.P.: “Lithium and Haloperidol in the Treatment of Huntington's Chorea”. Paper presented at the Australian and New Zealand College of Psychiatrists’ Congress, Perth, 1974 (cited from G.F.S. Johnson's paper, 1976).
ShopsinB., GershonS.: “Pharmacology-Toxicology of the Lithium Ion” in Lithium: Its Role In Psychiatric Research and Treatment.GershonS., ShopsinB. (eds), New York: Plenum Press, 1973, 107–146.
11.
ShopsinB., JohnsonG., GershonS.: Neurotoxicity with lithium: Differential drug responsiveness.Int Pharmacopsychiatry, 5: 170–182, 1970.
12.
SmithD.F., ShimizuF., SchouM.: Lithium absorption, distribution and clearance and body temperature in rats given lithium plus haloperidol.Pharmacology (Basel), 15: 337–340, 1977.
13.
SpringG.K.: Neurotoxicity with combined use of lithium and thioridazine.J Clin Psychiatry, 40: 135–138, 1979.
14.
StrayhornJ.M., NashJ.L.: Severe neurotoxicity despite “therapeutic” serum lithium levels.Dis Nerv Syst, 38: 107–111, 1977.
15.
WestA.P., MeltzerH.Y.: Paradoxical lithium neurotoxicity: A report of five cases and a hypothesis about risk for neurotoxicity.Am J Psychiatry, 136: 963–966, 1979.